Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Aehr Test Systems Reports Fiscal 2025 Third Quarter Revenue Growth and Solid Bookings and Backlog

In This Article:

Company temporarily withdraws guidance due to ongoing tariff uncertainty

FREMONT, CA / ACCESS Newswire / April 8, 2025 / Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced financial results for its third quarter of fiscal 2025 ended February 28, 2024.

Fiscal Third Quarter Financial Results:

  • Net revenue was $18.3 million, compared to $7.6 million in the third quarter of fiscal 2024.

  • GAAP net loss was $(0.6) million, or $(0.02) per diluted share, compared to a GAAP net loss of $(1.5) million, or $(0.05) per diluted share, in the third quarter of fiscal 2024.

  • Non-GAAP net income, which excludes the impact of stock-based compensation, acquisition-related costs and adjustments, and charges related to an executive officer's death related accelerated benefits, was $2.0 million, or $0.07 per diluted share, compared to a non-GAAP net loss of $(0.9) million, or $(0.03) per diluted share, in the third quarter of fiscal 2024.

  • Bookings were $24.1 million for the quarter.

  • Backlog as of February 28, 2025 was $18.2 million. Effective backlog, including bookings since February 28, 2025, is $21.8 million.

  • Total cash, cash equivalents and restricted cash as of February 28, 2025 was $31.4 million, compared to $35.2 million as of November 29, 2024.

Fiscal First Nine Months Financial Results:

  • Net revenue was $44.9 million, compared to $49.6 million in the first nine months of fiscal 2024.

  • GAAP net loss was $(1.0) million, or $(0.03) per diluted share, compared to GAAP net income of $9.3 million, or $0.31 per diluted share, in the first nine months of fiscal 2024.

  • Non-GAAP net income was $4.8 million, or $0.16 per diluted share, which excludes the impact of stock-based compensation, acquisition-related costs and adjustments, and charges related to accelerated benefits, compared to non-GAAP net income of $11.0 million, or $0.37 per diluted share, in the first nine months of fiscal 2024.

  • Cash used in operating activities was $5.1 million for the first nine months of fiscal 2025.

An explanation of the use of non-GAAP financial measures and a reconciliation of Aehr's non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the accompanying tables.

Gayn Erickson, President and CEO of Aehr Test Systems, commented:

"We have been laser-focused on the initiatives we set out to expand our total addressable markets, diversify our customer base, and develop new products, capabilities, and capacity to grow our business moving forward. We are excited by the significant progress we've made this year in expanding into new key markets and unlocking new opportunities to attract customers and drive revenue growth, particularly in diversifying our markets and customers beyond our revenue concentration last fiscal year from silicon carbide (SiC) wafer level burn-in (WLBI).